Xvivo Perfusion AB (XVIPF)
19.00
0.00 (0.00%)
USD |
OTCM |
Nov 18, 16:00
Xvivo Perfusion Market Cap : 598.49M for Nov. 18, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 18, 2026 | 598.49M |
| November 17, 2026 | 598.49M |
| November 16, 2026 | 631.56M |
| November 13, 2026 | 631.56M |
| November 12, 2026 | 631.56M |
| November 11, 2026 | 631.56M |
| November 10, 2026 | 631.56M |
| November 09, 2026 | 631.56M |
| November 06, 2026 | 631.56M |
| November 05, 2026 | 682.91M |
| November 04, 2026 | 682.91M |
| November 03, 2026 | 682.91M |
| November 02, 2026 | 682.91M |
| October 30, 2026 | 682.91M |
| October 29, 2026 | 682.91M |
| October 28, 2026 | 682.91M |
| October 27, 2026 | 682.91M |
| October 26, 2026 | 682.91M |
| October 23, 2026 | 682.91M |
| October 22, 2026 | 686.69M |
| October 21, 2026 | 686.69M |
| October 20, 2026 | 686.69M |
| October 19, 2026 | 686.69M |
| October 16, 2026 | 686.69M |
| October 15, 2026 | 686.69M |
| Date | Value |
|---|---|
| October 14, 2026 | 686.69M |
| October 13, 2026 | 686.69M |
| October 12, 2026 | 686.69M |
| October 09, 2026 | 686.69M |
| October 08, 2026 | 686.69M |
| October 07, 2026 | 686.69M |
| October 06, 2026 | 686.69M |
| October 05, 2026 | 686.69M |
| October 02, 2026 | 686.69M |
| October 01, 2026 | 719.76M |
| September 30, 2026 | 719.76M |
| September 29, 2026 | 719.76M |
| September 28, 2026 | 787.80M |
| September 25, 2026 | 787.80M |
| September 24, 2026 | 787.80M |
| September 23, 2026 | 787.80M |
| September 22, 2026 | 787.80M |
| September 21, 2026 | 802.61M |
| September 18, 2026 | 802.61M |
| September 17, 2026 | 802.61M |
| September 16, 2026 | 974.91M |
| September 15, 2026 | 974.91M |
| September 14, 2026 | 974.91M |
| September 11, 2026 | 974.91M |
| September 10, 2026 | 974.91M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Getinge AB | 6.913B |
| Paxman AB | 81.46M |
| Enovis Corp. | 1.564B |
| Edwards Lifesciences Corp. | 60.57B |
| Intuitive Surgical, Inc. | 145.90B |
Market Cap Related Metrics
| PE Ratio | 43.75 |
| PS Ratio | 5.869 |
| PEG Ratio | 0.1134 |
| Price to Book Value | 2.636 |
| Price to Free Cash Flow | 21.32 |
| Price | 19.00 |
| Earnings Yield | 2.29% |
| PEGY Ratio | 0.1134 |
| Operating PE Ratio | 48.38 |
| Normalized PE Ratio | 43.75 |